MTOR (mechanistic target of rapamycin) inhibition is a research area focused on blocking the activity of the mTOR protein, which plays a key role in regulating cell growth, proliferation, and survival. Dysregulation of mTOR signaling has been implicated in the development of various diseases, including cancer, autoimmune disorders, and metabolic diseases. MTOR inhibitors, such as rapamycin and its derivatives, are being studied as potential therapeutic agents for these diseases. By inhibiting mTOR, these drugs can help to slow down cell growth and proliferation, and potentially induce cell death in cancer cells. Research in this area is ongoing, with scientists exploring the mechanism of action of mTOR inhibitors, the development of new and more effective inhibitors, and the potential clinical applications of these drugs in various disease settings.